|
IT1016489B
(it)
|
1974-03-18 |
1977-05-30 |
Isf Spa |
Inalatore
|
|
DE2947526A1
(de)
|
1978-11-29 |
1980-06-12 |
Ono Pharmaceutical Co |
Prostacyclin-analoge
|
|
US4668814A
(en)
|
1984-03-08 |
1987-05-26 |
The Upjohn Company |
Interphenylene carbacyclin derivatives
|
|
JPS61289034A
(ja)
|
1985-06-17 |
1986-12-19 |
Teijin Ltd |
イソカルバサイクリン類脂肪乳剤
|
|
US4837342A
(en)
|
1986-02-28 |
1989-06-06 |
Sagami Chemical Research Center |
Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient
|
|
GB8814438D0
(en)
|
1988-06-17 |
1988-07-20 |
Wellcome Found |
Compounds for use in medicine
|
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
|
IT1240750B
(it)
|
1990-04-12 |
1993-12-17 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di sostanze medicamentose in polvere
|
|
GB9011588D0
(en)
|
1990-05-24 |
1990-07-11 |
Wellcome Found |
Prostaglandin analogues for use in medicine
|
|
GB9015522D0
(en)
|
1990-07-13 |
1990-08-29 |
Braithwaite Philip W |
Inhaler
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
CA2056039A1
(en)
|
1991-01-22 |
1992-07-23 |
Philip L. Fuchs |
Carbacyclin analogs
|
|
US5190972A
(en)
|
1992-01-27 |
1993-03-02 |
The University Of Melbourne |
Method of combatting cyclosporine organ toxicity with prostaglandin analogs
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
US5785049A
(en)
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
|
DK0674533T3
(da)
|
1992-12-18 |
1999-09-27 |
Schering Corp |
Inhalator for medikamenter i pulverform
|
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
|
GB9306703D0
(en)
|
1993-03-31 |
1993-05-26 |
Fisons Plc |
Inhalation device
|
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
|
SE9302550D0
(sv)
|
1993-07-30 |
1993-07-30 |
Ernst Hoerlin |
Powder inhaler
|
|
PT101450B
(pt)
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
|
FI95441C
(fi)
|
1994-05-31 |
1996-02-12 |
Leiras Oy |
Inhalointilaitteen lääkeainekammio
|
|
FR2725626A1
(fr)
|
1994-10-18 |
1996-04-19 |
Sofab |
Dispositif pour l'inhalation de produits en poudre
|
|
SE9404439D0
(sv)
|
1994-12-21 |
1994-12-21 |
Astra Ab |
Inhalation device
|
|
ES2216418T3
(es)
|
1995-12-07 |
2004-10-16 |
Jago Research Ag |
Boquilla para un inhalador para la administracion de varias dosis de un polvo seco farmacologico.
|
|
US5797392C1
(en)
|
1996-01-22 |
2001-01-09 |
Direct Haler As |
Inhaler
|
|
US6026809A
(en)
|
1996-01-25 |
2000-02-22 |
Microdose Technologies, Inc. |
Inhalation device
|
|
AU5719798A
(en)
|
1996-12-31 |
1998-07-31 |
Inhale Therapeutic Systems, Inc. |
Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
|
|
PT101988B
(pt)
|
1997-04-04 |
2004-02-27 |
Hovione Farmaciencia Sa |
Sistema de orientacao e posicionamento de um objecto
|
|
US6638621B2
(en)
|
2000-08-16 |
2003-10-28 |
Lyotropic Therapeutics, Inc. |
Coated particles, methods of making and using
|
|
KR100638684B1
(ko)
|
1997-11-14 |
2006-10-27 |
유나이티드 세러퓨틱스 코오포레이션 |
말초 혈관 질환의 치료를 위한 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘 에프1의 용도
|
|
US6919372B1
(en)
|
1997-12-26 |
2005-07-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Sustained release pharmaceutical compositions
|
|
GB9805102D0
(en)
|
1998-03-10 |
1998-05-06 |
Ciba Geigy Ag |
Device
|
|
US6257233B1
(en)
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
|
WO1999066903A2
(en)
|
1998-06-24 |
1999-12-29 |
Advanced Inhalation Research, Inc. |
Large porous particles emitted from an inhaler
|
|
JP2002521423A
(ja)
|
1998-07-31 |
2002-07-16 |
コリア インスティチュート オブ サイエンス アンド テクノロージ |
遺伝子又は薬物運搬体としての脂質エマルジョン及び固形脂質微粒子
|
|
CA2341624C
(en)
|
1998-08-25 |
2008-12-02 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
|
US6265495B1
(en)
|
1998-09-22 |
2001-07-24 |
Nippon Shokubai Co., Ltd. |
Method for production of esterified product
|
|
IT1309592B1
(it)
|
1999-03-05 |
2002-01-24 |
Chiesi Farma Spa |
Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
|
|
ATE363892T1
(de)
|
1999-03-05 |
2007-06-15 |
Chiesi Farma Spa |
Verbesserte pulverformulierungen zur inhalation
|
|
US6521212B1
(en)
|
1999-03-18 |
2003-02-18 |
United Therapeutics Corporation |
Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
|
|
CA2359652A1
(en)
|
1999-03-31 |
2000-10-05 |
United Therapeutics Corporation |
Novel prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of peripheral vascular disease and pulmonaryhypertension
|
|
ITMI991582A1
(it)
|
1999-07-16 |
2001-01-16 |
Chiesi Farma Spa |
Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
|
|
CA2400349C
(en)
|
2000-03-10 |
2009-11-10 |
University Of North Carolina At Chapel Hill |
Dry powder inhaler devices, multi-dose dry powder drug packages, control systems, and associated methods
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
US6242482B1
(en)
|
2000-06-05 |
2001-06-05 |
United Therapeutics Corporation |
Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
|
|
US6306435B1
(en)
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
|
US6766799B2
(en)
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
|
US6848197B2
(en)
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
|
US6991809B2
(en)
|
2001-06-23 |
2006-01-31 |
Lyotropic Therapeutics, Inc. |
Particles with improved solubilization capacity
|
|
US20030108512A1
(en)
|
2001-12-10 |
2003-06-12 |
Robert Shorr |
Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
|
|
US6803386B2
(en)
|
2002-01-16 |
2004-10-12 |
United Therapeutics Corporation |
Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
|
|
US20040156816A1
(en)
|
2002-08-06 |
2004-08-12 |
David Anderson |
Lipid-drug complexes in reversed liquid and liquid crystalline phases
|
|
US20040102469A1
(en)
|
2002-09-13 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for reducing the mortality rate
|
|
GB0222023D0
(en)
|
2002-09-21 |
2002-10-30 |
Aventis Pharma Ltd |
Inhaler
|
|
US7763280B2
(en)
|
2002-11-28 |
2010-07-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing powder formulation for inhalation
|
|
CA2524538A1
(en)
|
2003-05-19 |
2004-12-02 |
Baxter International Inc. |
Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers
|
|
ES2272914T3
(es)
|
2003-05-20 |
2007-05-01 |
Ethypharm |
Composicion farmaceutica oral de liberacion sostenida.
|
|
ES2622471T5
(es)
|
2003-05-22 |
2020-07-23 |
United Therapeutics Corp |
Compuestos y procedimientos para la administración de análogos de prostaciclina
|
|
ES2289221T3
(es)
|
2003-10-06 |
2008-02-01 |
BANG & OLUFSEN MEDICOM A/S |
Inhalador.
|
|
GB2407042B
(en)
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
|
DE602004028155D1
(de)
|
2003-12-16 |
2010-08-26 |
United Therapeutics Corp |
Verwendung von treprostinil zur behandlung von ischämischen läsionen
|
|
ATE441418T1
(de)
|
2003-12-16 |
2009-09-15 |
United Therapeutics Corp |
Verwendung von treprostinil zur verbesserung der nierenfunktion
|
|
WO2005099680A2
(en)
|
2004-04-12 |
2005-10-27 |
United Therapeutics, Inc. |
Use of treprostinil to treat neuropathic diabetic foot ulcers
|
|
GB0416328D0
(en)
*
|
2004-07-21 |
2004-08-25 |
Univ Cardiff |
Use of dry powder compositions for pulmonary delivery
|
|
JP2008507585A
(ja)
|
2004-07-26 |
2008-03-13 |
コセリックス インク |
微粒子製剤を用いて吸入したイロプロストによる肺高血圧症の治療
|
|
JP4893999B2
(ja)
|
2004-10-22 |
2012-03-07 |
小野薬品工業株式会社 |
吸入用医薬組成物
|
|
CA2631493A1
(en)
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
EP2026816B1
(en)
|
2006-05-15 |
2018-10-24 |
United Therapeutics Corporation |
Treprostinil administration using a metered dose inhaler
|
|
US20090036465A1
(en)
|
2006-10-18 |
2009-02-05 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
JP2010518122A
(ja)
|
2007-02-09 |
2010-05-27 |
ユナイテッド セラピューティクス コーポレーション |
間質性肺疾患および喘息のためのトレプロスチニル処置
|
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ（アミノ酸）ターゲッティング部分
|
|
US8496002B2
(en)
|
2007-06-12 |
2013-07-30 |
Civitas Therapeutics, Inc. |
Powder inhaler devices
|
|
CN103181893A
(zh)
|
2007-09-07 |
2013-07-03 |
联合治疗公司 |
针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
|
|
CN101903324B
(zh)
|
2007-12-17 |
2013-07-03 |
联合治疗公司 |
一种制备Remodulin中的活性成分曲前列素的改良方法
|
|
CA2723540C
(en)
|
2008-05-08 |
2016-01-05 |
United Therapeutics Corporation |
Treprostinil monohydrate
|
|
WO2009152160A1
(en)
|
2008-06-10 |
2009-12-17 |
Gilead Sciences, Inc. |
Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension
|
|
WO2009158010A1
(en)
|
2008-06-27 |
2009-12-30 |
Concert Pharmaceuticals, Inc. |
Prostacyclin analogs
|
|
WO2010039531A1
(en)
|
2008-09-23 |
2010-04-08 |
Resolvyx Pharmaceuticals, Inc. |
Therapeutic compounds
|
|
CN102164487A
(zh)
|
2008-09-25 |
2011-08-24 |
阿拉迪姆公司 |
曲前列素的深肺部递送
|
|
RU2482851C2
(ru)
|
2009-02-20 |
2013-05-27 |
Микро Лабс Лимитед |
Хранение стабильного продукта простагландина
|
|
US8349892B2
(en)
|
2009-05-07 |
2013-01-08 |
United Therapeutics Corporation |
Solid formulations of prostacyclin analogs
|
|
JP6087147B2
(ja)
|
2009-06-22 |
2017-03-01 |
ジョンソン、マッセイ、パブリック、リミテッド、カンパニーＪｏｈｎｓｏｎ Ｍａｔｔｈｅｙ Ｐｕｂｌｉｃ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ |
プロスタグランジンの精製方法
|
|
US20120270934A1
(en)
|
2009-07-03 |
2012-10-25 |
Concert Pharmaceuticals, Inc. |
Prostacyclin derivatives
|
|
RS53234B
(sr)
|
2009-08-07 |
2014-08-29 |
Scipharm Sàrl |
Kompozicija za lečenje cistične fibroze
|
|
GB2486371A
(en)
|
2009-08-21 |
2012-06-13 |
Targeted Delivery Technologies Ltd |
Vesicular formulations
|
|
CN101669904B
(zh)
|
2009-09-29 |
2011-06-22 |
北京中海康医药科技发展有限公司 |
一种依前列醇脂质纳米粒及制备方法
|
|
WO2011089215A1
(en)
|
2010-01-22 |
2011-07-28 |
Ascendis Pharma As |
Dipeptide-based prodrug linkers for aromatic amine-containing drugs
|
|
US9062094B2
(en)
|
2010-01-22 |
2015-06-23 |
Ascendis Pharma As |
Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
|
|
ES2611187T3
(es)
|
2010-03-15 |
2017-05-05 |
United Therapeutics Corporation |
Tratamiento para hipertensión pulmonar
|
|
JP6046034B2
(ja)
|
2010-06-03 |
2016-12-14 |
ユナイテッド セラピューティクス コーポレイション |
トレプロスチニルの製造
|
|
US20120004307A1
(en)
|
2010-06-15 |
2012-01-05 |
United Therapeutics Corporation |
Oral treatment of digital ischemic lesions
|
|
US20120010159A1
(en)
|
2010-07-09 |
2012-01-12 |
United Therapeutics Corporation |
Combination therapies with cox-2 inhibitors and treprostinil
|
|
CA2710726C
(en)
|
2010-07-22 |
2016-02-23 |
Alphora Research Inc. |
Synthesis of treprostinil and intermediates useful therein
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
JP5780775B2
(ja)
|
2011-02-18 |
2015-09-16 |
株式会社Ｌｔｔバイオファーマ |
プロスタグランジンｉ２誘導体を含有するナノ粒子
|
|
US20130345471A1
(en)
|
2011-03-02 |
2013-12-26 |
United Therapeutics Corporation |
Synthesis of intermediate for treprostinil production
|
|
ES2832330T3
(es)
|
2011-03-14 |
2021-06-10 |
Univ Hokkaido Nat Univ Corp |
Vector para administración pulmonar, agente inductor y usos
|
|
EP2741778A1
(en)
|
2011-08-12 |
2014-06-18 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
|
AU2012296951B2
(en)
|
2011-08-12 |
2016-09-15 |
Ascendis Pharma A/S |
Protein carrier-linked prodrugs
|
|
HK1198358A1
(en)
|
2011-08-12 |
2015-04-10 |
Ascendis Pharma A/S |
Sustained release composition of prostacyclin
|
|
CA2843506C
(en)
|
2011-08-12 |
2020-05-12 |
Ascendis Pharma A/S |
Carrier-linked prodrugs having reversible carboxylic ester linkages
|
|
CA2843875C
(en)
|
2011-08-12 |
2020-01-07 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
|
MX349950B
(es)
|
2011-08-12 |
2017-08-22 |
Ascendis Pharma As |
Profarmacos de treprostinil enlazados a un portador.
|
|
US8524939B2
(en)
|
2011-08-24 |
2013-09-03 |
Chirogate International Inc. |
Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
|
|
US9387214B2
(en)
|
2012-01-13 |
2016-07-12 |
United Therapeutics Corporation |
Method of identifying therapies for pulmonary hypertension
|
|
LT2674413T
(lt)
|
2012-06-15 |
2017-09-25 |
Scipharm Sąrl |
Treprostinilo ir jo darinių gavimo būdas
|
|
EP2879682B1
(en)
|
2012-08-01 |
2018-03-21 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
|
ES2713988T3
(es)
|
2012-08-01 |
2019-05-24 |
United Therapeutics Corp |
Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
|
|
AU2013351934B2
(en)
*
|
2012-11-30 |
2018-03-29 |
Insmed Incorporated |
Prostacylin compositions and methods for using the same
|
|
EP2943069B1
(en)
|
2013-01-09 |
2018-08-15 |
United Therapeutics Corporation |
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
|
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
EP3712142B1
(en)
|
2013-01-11 |
2022-07-06 |
Corsair Pharma, Inc. |
Prodrugs of treprostinil
|
|
JP2016517410A
(ja)
|
2013-03-14 |
2016-06-16 |
ユナイテッド セラピューティクス コーポレイション |
トレプロスチニルの固体形態
|
|
CN109608326A
(zh)
|
2013-03-15 |
2019-04-12 |
联合治疗公司 |
曲前列环素的盐
|
|
JP6263604B2
(ja)
|
2013-03-25 |
2018-01-17 |
ユナイテッド セラピューティクス コーポレイション |
チオールリンカーを持つ、ペグ化型のプロスタサイクリン化合物の製造方法
|
|
US9758465B2
(en)
|
2013-04-30 |
2017-09-12 |
United Therapeutics Corporation |
Controlled release pharmaceutical formulations
|
|
WO2014203278A2
(en)
|
2013-06-19 |
2014-12-24 |
Msn Laboratories Private Limited |
NOVEL PROCESS FOR THE PREPARATION OF (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-HEXAHYDRO-2-HYDROXY-1-[(3S)-3-HYDROXYOCTYL]-1H-BENZ[f]INDEN-5-YL]OXY]ACETIC ACID
|
|
US9925184B2
(en)
*
|
2013-10-11 |
2018-03-27 |
Pulmokine, Inc. |
Spray-dry formulations
|
|
ES2860975T3
(es)
|
2013-10-25 |
2021-10-05 |
Insmed Inc |
Compuestos de prostaciclina
|
|
WO2015138423A1
(en)
|
2014-03-11 |
2015-09-17 |
Insmed Incorporated |
Prostacylin compositions and methods for using the same
|
|
ES2908142T3
(es)
|
2014-06-13 |
2022-04-27 |
United Therapeutics Corp |
Formulaciones de treprostinil
|
|
RU2732908C2
(ru)
|
2014-10-07 |
2020-09-24 |
ЭйАй ТЕРАПЬЮТИКС, ИНК. |
Ингаляционная лекарственная форма рапамицина для лечения легочной гипертензии
|
|
US9593061B2
(en)
|
2014-10-20 |
2017-03-14 |
United Therapeutics Corporation |
Synthesis of intermediates for producing prostacyclin derivatives
|
|
AU2015349969B2
(en)
*
|
2014-11-18 |
2020-02-06 |
Insmed Incorporated |
Methods of manufacturing treprostinil and treprostinil derivative prodrugs
|
|
US20160318844A1
(en)
|
2015-04-29 |
2016-11-03 |
Insmed Incorporated |
Prostacyclin compounds, compositions and methods of use thereof
|
|
US20180200186A1
(en)
*
|
2015-07-09 |
2018-07-19 |
Insmed Incorporated |
Compositions and methods for treating lung diseases and lung injury
|
|
IL262720B2
(en)
|
2016-05-05 |
2024-06-01 |
Liquidia Tech Inc |
Dry powder treprostinil for the treatment of pulmonary hypertension
|
|
WO2017223400A1
(en)
|
2016-06-24 |
2017-12-28 |
Insmed Incorporated |
Prostacyclin compounds and compositions for treating sarcoidosis
|
|
JP7220650B2
(ja)
|
2016-09-26 |
2023-02-10 |
ユナイテッド セラピューティクス コーポレイション |
トレプロスチニルプロドラッグ
|
|
CA3102967A1
(en)
|
2018-06-07 |
2019-12-12 |
Mannkind Corporation |
Composition and method for inhalation
|
|
EP3673895A1
(en)
|
2018-12-28 |
2020-07-01 |
Université Libre de Bruxelles |
Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
|
|
CN114072136B
(zh)
|
2019-04-29 |
2024-11-29 |
英斯梅德股份有限公司 |
曲前列素前药的干粉组合物及其使用方法
|
|
US20240238309A1
(en)
|
2020-03-25 |
2024-07-18 |
Insmed Incorporated |
Pharmaceutical formulations of treprostinil prodrugs and methods of use thereof
|
|
WO2022094100A1
(en)
|
2020-10-28 |
2022-05-05 |
Insmed Incorporated |
Dry powder compositions of treprostinil prodrugs and methods of use thereof
|
|
JP2024510930A
(ja)
|
2021-03-03 |
2024-03-12 |
ユナイテッド セラピューティクス コーポレイション |
トレプロスチニル及びそのプロドラッグの乾燥粉末組成物、及び、さらに（ｅ）－３，６－ビス［４－（ｎ－カルボニル－２－プロペニル）アミドブチル］－２，５－ジケトピペラジン（ｆｄｋｐ）を含む乾燥粉末組成物
|
|
CN114652704A
(zh)
|
2022-04-29 |
2022-06-24 |
兆科药业（广州）有限公司 |
一种曲前列尼尔软雾吸入剂
|